Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Pharmacoepidemiology and Drug Safety|November 27, 2024
Validity of Pharmaceutical Claims Data for Determining Medication Exposure in Long-Term Care FacilitiesEmma Pearce, Geraint Rogers, Lucy Carpenter, et al.
The Lancet. Infectious Diseases|July 22, 2014
Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort studyNick J Andrews, Pauline A Waight, Polly Burbidge, et al.
Scientific Reports|July 11, 2024
Single-frame transmission and phase imaging using off-axis holography with undetected photonsEmma Pearce, Osian Wolley, Simon P Mekhail, et al.
Vaccine|December 17, 2014
Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation scheduleShamez N Ladhani, Nick J Andrews, Pauline Waight, et al.
Msphere|June 21, 2019
Assignment of Serotype-Specific IgG1, IgG2, and IgA Weight-Based Antibody Units to the Human Pneumococcal Standard Reference Serum, 007spScott Jones, Kier Finnegan, Jae Hee Wee, et al.
The Lancet. Infectious Diseases|July 10, 2023
Population immunity to pneumococcal serotypes in Kilifi, Kenya, before and 6 years after the introduction of PCV10 with a catch-up campaign: an observational study of cross-sectional serosurveysKatherine E Gallagher, Ifedayo M O Adetifa, Caroline Mburu, et al.
Vaccine|April 12, 2023
Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (SynflorixTM and Prevenar13TM)) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-labelled randomized controlled trial in Indian childrenAnand Kawade, Girish Dayma, Aditi Apte, et al.
Plos Medicine|April 19, 2022
Temporal trends in associations between severe mental illness and risk of cardiovascular disease: A systematic review and meta-analysisAmanda M Lambert, Helen M Parretti, Emma Pearce, et al.
The Lancet. Infectious Diseases|August 27, 2022
Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3 + 0 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population-level, serosurveillance studyTodd D Swarthout, Marc Y R Henrion, Deus Thindwa, et al.
Vaccine|April 12, 2023
Pneumococcal carriage following PCV13 delivered as one primary and one booster dose (1 + 1) compared to two primary doses and a booster (2 + 1) in UK infantsDavid Goldblatt, Nick J Andrews, Carmen L Sheppard, et al.
Pageof 3